GBL GAMCO Investors

2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020

Join us as we discuss today’s pressing healthcare issues.

This press release features multimedia. View the full release here:

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

CO-HOSTS:

Bunny Ellerin

Director, HPM, Columbia Business School

Jing He

Biotech Analyst, Gabelli Funds

  • MBA, Harvard Business School
  • BA, Columbia University
  • MBA, Columbia Business School
  • MA, Washington University in St. Louis
  • BS, Peking University

Time

Agenda

9:00 – 9:10 AM

Welcome

  • Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program

9:10 – 10:00 AM

Vaccines & Therapeutics to Treat COVID-19

  • David Hering, Regional President, North America, Pfizer Vaccines
  • Dr. Robert Paris, Vice President, Infectious Diseases, Moderna
  • Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron
  • (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds

10:10 – 11:00 AM

Health Policy & Reimbursement Trends

  • Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, NewYork-Presbyterian
  • Melissa Schulman, Senior Vice President of Government Affairs, CVS Health
  • Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health
  • (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds

11:10 – Noon

Healthcare Delivery in a Virtual World

  • Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery
  • Jason Gorevic, CEO, Teladoc Health
  • Dr. Julie Silverstein, Divisional President, Oak Street Health
  • (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

EN
02/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GAMCO Investors

 PRESS RELEASE

GAMCO Investors, Inc. Reports Results for the Fourth Quarter 2025 and ...

GAMCO Investors, Inc. Reports Results for the Fourth Quarter 2025 and Year Ended December 31, 2025 Enhancing and Expanding our ETF Product OfferingsQuarter End AUM of $34.9 Billion (+10% versus Q4 2024)Quarterly Revenues Grew 10.7% to $65.6 MillionFourth Quarter EPS of $0.75 versus $0.64 in the Fourth Quarter of 20242025 Earnings of $3.17 per Share versus $2.58 per Share in 2024Strong Liquidity Position and Cash Generation Support Capital Returns: $195.5 Million in Cash and Investments with No Debt; 22.0 Million Shares Outstanding After Repurchasing 103,871 Shares During Q4 2025 GREENWICH,...

 PRESS RELEASE

GAMCO Investors, Inc. to Make Nomination to the Boards of Saba Capital...

GAMCO Investors, Inc. to Make Nomination to the Boards of Saba Capital Management Closed-End Funds GREENWICH, Conn., Feb. 02, 2026 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“Gabelli”) (OTCQX: GAMI) today announced that certain of its affiliates intend to nominate David Schachter for election as a Trustee to the Boards of the Saba Income & Capital Opportunities Fund (NYSE: BRW) and the Saba Capital Income & Opportunities Fund II (NYSE: SABA), both closed-end funds (the “Funds”) managed by Saba Capital Management L.P. The Funds currently trade at discounts to their net asset values—approx...

 PRESS RELEASE

GAMCO Expects to Report Diluted EPS for the Fourth Quarter 2025 of $0....

GAMCO Expects to Report Diluted EPS for the Fourth Quarter 2025 of $0.67 to $0.73 Per Share and 2025 Diluted EPS of $3.09 to $3.15 Per Share GREENWICH, Conn., Jan. 05, 2026 (GLOBE NEWSWIRE) -- GAMCO Investors, Inc. (“Gabelli”) (OTCQX: GAMI) announced today that assets under management (“AUM”) were $34.8 billion at December 31, 2025 as compared to $31.7 billion at December 31, 2024. Gabelli expects to report fourth quarter 2025 diluted earnings in the range of $0.67 to $0.73 per share versus $0.64 per share for the fourth quarter of 2024. GAMI expects to report 2025 diluted earnings in th...

 PRESS RELEASE

GAMCO Investors, Inc. Reports Results for the Third Quarter 2025

GAMCO Investors, Inc. Reports Results for the Third Quarter 2025 Enhancing and Expanding our ETF Product OfferingsQuarter End AUM of $35.0 billion (+9% versus Q3 2024)Quarterly Revenues Grew 10% to $63.2 millionThird Quarter EPS of $0.68 versus $0.69 in the Third Quarter of 2024Strong Liquidity Position and Cash Generation Support Capital Returns: $200.8 million in Cash and Investments (No Debt); 22.1 million Shares Outstanding After Repurchasing 237,000 Shares During Q3 2025Board Authorizes 25% Increase to Quarterly Dividend to $0.10 Per Share, an Additional 500,000 Share Buyback, and $2.5...

 PRESS RELEASE

GAMCO Investors, Inc. Reports Results for the Third Quarter 2025

GAMCO Investors, Inc. Reports Results for the Third Quarter 2025 Enhancing and Expanding our ETF Product OfferingsQuarter End AUM of $35.0 billion (+9% versus Q3 2024)Quarterly Revenues Grew 10% to $63.2 millionThird Quarter EPS of $0.68 versus $0.69 in the Third Quarter of 2024Strong Liquidity Position and Cash Generation Support Capital Returns: $200.8 million in Cash and Investments (No Debt); 22.1 million Shares Outstanding After Repurchasing 237,000 Shares During Q3 2025Board Authorizes 25% Increase to Quarterly Dividend to $0.10 Per Share, an Additional 500,000 Share Buyback, and $2.5...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch